RHHBY
Roche Holding$30.58
RHHBY info-0.03%ย โ€ข 24 H
Dividend Yield:4.3%
Global Rank#54
Market Cap$195.38B
YTD Performance-15.24%
P/E0
Revenue$66.28B
Change 7d-0.07%
SP500 BenchmarkUnderperform
P/S2.95
Earnings$13.55B

Roche Holding (RHHBY) Stock Overview

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD); and strategic agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize zilebesiran. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.

RHHBY Stock Information

SymbolRHHBY
Address
Grenzacherstrasse 124Basel, 4058Switzerland
Founded-
Trading hours-
Websitehttps://www.roche.com
Country๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Phone Number41 61 688 11 11

Roche Holding (RHHBY) Price Chart

-
Value:-

Roche Holding Overview: Key Details and Summary

Stock data
2023
Change
Price
$30.58
N/A
Market Cap
$195.38B
N/A
Shares Outstanding
6.39B
-0.17%
Employees
103.61K
N/A
Shareholder Equity
33.26B
-3.08%
Valuation
2023
Change
P/S Ratio
2.95
N/A
P/B Ratio
5.87
N/A
P/FCF
15.57
N/A
Dividends
2023
Change
Dividend Yield
4.26%
N/A
Dividend per share
1.3027
N/A
Dividend Payout Ratio
0.6142
N/A
Growth
2023
Change
ROIC
0.1873
N/A
CAPEX
-3.91B
N/A
Return on Equity
0.1088
N/A
Earnings
2023
Change
Revenue
$66.28B
N/A
Earnings
$13.55B
N/A
Free Cash Flow
$12.55B
N/A
Gross Margin
0.7294
N/A
Operating Margin
0.2547
N/A
Net income margin
0.2045
N/A
FCF Margin
0.1894
N/A
Financial Strength
2023
Change
Total Assets
$99.21B
N/A
Total Debt
$33.76B
N/A
Cash on Hand
$11.53B
N/A
Debt to Equity
$1.89
62.01%
Cash to Debt
0.3414
-14.71%
Current Ratio
$1.35
-27.03%
ยฉ 2024 TopStocks.org
Facebook Icon
Twitter Icon
Linkedin Icon